On Assignment Reports Results for First Quarter 2013

  On Assignment Reports Results for First Quarter 2013

Revenues, Income, EPS & Adjusted EBITDA above High-end of Previously Announced
                                  Estimates

Business Wire

CALABASAS, Calif. -- April 24, 2013

On Assignment, Inc. (NYSE: ASGN), a leading global provider of diversified
professional staffing solutions, today reported results for the quarter ended
March 31, 2013.

First Quarter Highlights

  *Revenues were $389.2 million, up 13.6 percent year-over-year on a pro
    forma basis and 2.3 percent sequentially. Pro forma results, as used
    herein, assume that our acquisition of Apex Systems occurred on January 1,
    2012. Pro forma operating results are summarized in a table below.
  *Income from continuing operations was $10.6 million ($0.20 per diluted
    share), up from $9.7 million ($0.18 per diluted share) in the fourth
    quarter of 2012 and $5.0 million ($0.13 per diluted share) in the first
    quarter of 2012. Income from continuing operations excludes the operating
    results of the Nurse Travel division, which are reported as discontinued
    operations.
  *Adjusted income from continuing operations (a non-GAAP measure set forth
    in the table below) was $18.8 million ($0.35 per diluted share).
  *Adjusted EBITDA (a non-GAAP measure defined below) was $34.1 million, up
    from $28.4 million in Q1 of 2012 on a pro forma basis.
  *Adjusted EBITDA margin of 8.8 percent, up from 8.3 percent in Q1 2012 on a
    pro forma basis.
  *Effective tax rate was 42.3 percent.
  *Percentage of gross profit converted into operating income was 21.0
    percent, up from 17.9 percent in Q1 2012 on a pro forma basis. The
    percentage of gross profit converted into Adjusted EBITDA was 30.1
    percent, up from 27.8 percent in Q1 2012 on a pro forma basis.
  *Leverage ratio (total indebtedness to trailing twelve months Adjusted
    EBITDA) was 2.49 to 1, down from 2.88 to 1 at December 31, 2012.

Commenting on the results, Peter Dameris, President and Chief Executive
Officer of On Assignment, Inc., said, “Results for the quarter reflect a
strong start for 2013. We believe we are well positioned to meet or exceed our
financial targets for the full year. Demand for our services is strong and in
most of our segments our growth is outpacing the market. We are also seeing
steady improvement in our operating efficiency as evidenced by the
year-over-year expansion in our Adjusted EBITDA margin and the improvement in
the percentage of gross profit we converted into operating income and Adjusted
EBITDA.

“The supply of technical resources continues to tighten, which provides us
with both opportunities and challenges. As these resources become scarcer, we
believe all our customers, large and small, will recognize the need to remain
competitive with compensation in order to timely acquire the talent they need
to execute their operating plans. This circumstance should result in higher
bill rates later in the year.”

Dameris continued, “We are currently working on a new $500 million credit
facility that will replace our existing facility. This new facility will
provide us with greater financial flexibility at a lower effective borrowing
rate. We expect this new facility will be in place by mid-May.”

First Quarter 2013 Results

Revenues were $389.2 million in the quarter, up 148 percent year-over-year and
2.3 percent on a sequential basis. On a pro forma basis, revenues were up 13.6
percent year-over-year. Revenues for Apex Systems were up 14.4 percent
year-over-year and revenues of the other business segments on a combined basis
were up 12.6 percent year-over-year.

Gross profit was $113.3 million, up 115 percent year-over-year and down 2.0
percent sequentially. The year-over-year growth was due to the inclusion of
Apex Systems, which accounted for $55.6 million, or 49.1 percent, of total
gross profit and the year-over-year organic growth of the other business
segments. The year-over-year compression in gross margin was mainly
attributable to the inclusion of Apex Systems, which has a lower gross margin
than the Company's other business segments.

Selling, general and administrative expenses were $84.2 million, up from $80.2
million in the fourth quarter of 2012. The sequential increase related to
headcount and other expenses added during the current and preceding quarters
mainly in the branches to drive growth in 2013 and in the corporate
departments to enhance our platform to support the larger organization.

Amortization of intangible assets was $5.4 million, down from $11.9 million in
the fourth quarter of 2012. The sequential decrease is attributable to an
adjustment made in Q4 of approximately $5.0 million for differences between
the finalized asset valuation and amortization rates for the customer
relationship intangible asset related to the acquisition of Apex Systems and
the preliminary determinations reflected in Q2 and Q3. Excluding the Q4
adjustment, amortization of intangible assets was down $1.5 million
sequentially.

Adjusted EBITDA (earnings before interest, taxes, depreciation, and
amortization of identifiable intangible assets plus equity-based compensation
expense, impairment charges, acquisition-related costs and fees and expenses
of the outside consulting firm assisting with the strategic planning
initiatives), was $34.1 million, up from $15.1 million in the first quarter of
2012, and $28.4 million on a pro forma basis. The Adjusted EBITDA margin
(Adjusted EBITDA as a percentage of revenues) was 8.8 percent compared with
8.3 percent on a pro forma basis for the first quarter of 2012.

The effective tax rate for the quarter was 42.3 percent compared with 43.1
percent for the full year 2012. The decrease in the effective tax rate related
to less impact on the effective tax rate for the full year of permanent
differences between financial reporting and taxable income.

Income from continuing operations was $10.6 million ($0.20 per diluted share)
compared with $5.0 million ($0.13 per diluted share) for the first quarter of
2012 and $6.9 million ($0.13 per diluted share) on a pro forma basis for the
first quarter of 2012. Income from continuing operations before income taxes
for the quarter included approximately $0.2 million in non-recurring
acquisition costs and $0.5 million related to fees and expenses of the
consulting firm assisting the company with its strategic planning.

Net income, which is comprised of income from continuing operations, the gain
on the sale of the Nurse Travel division and income from discontinued
operations, was $24.6 million ($0.46 per diluted share) compared with $11.3
million ($0.21 per diluted share) in Q1 of 2012.

Financial Estimates for Q2 2013

On Assignment is providing below financial estimates from continuing
operations for the second quarter of 2013. These estimates do not include
acquisition-related costs, strategic planning costs and the effects of the new
credit facility, including a lower effective interest rate and write-down of
deferred financing costs of the current facility.

  *Revenues of $410 million to $414 million
  *Gross Margin of 29.8 percent to 30.1 percent
  *SG&A (excludes amortization of intangible assets) of $86.5 to $87.5
    million (includes $2.2 million in depreciation and $3.7 million in
    equity-based compensation expense)
  *Amortization of intangible assets of $5.3 million
  *Adjusted EBITDA of $41 million to $43 million
  *Effective tax rate of 42.5 percent
  *Adjusted Income from Continuing Operations of $22.5 million to $23.5
    million
  *Adjusted Income from Continuing Operations per diluted share of $0.41 to
    $0.43
  *Income from Continuing Operations of $14.5 million to $15.5 million
  *Income from Continuing Operations per diluted share of $0.27 to $0.29
  *Diluted shares outstanding of 54.4 million

These estimates reflect normal seasonality in the business. The estimates
assume year-over-year revenue growth of approximately mid-teens growth for
Apex Systems and Oxford, mid-single digit growth for Life Sciences, high
single-digit growth for Physician Staffing and Allied Healthcare. The
estimates above assume no deterioration in the staffing markets that On
Assignment serves. For the full year, the Company expects to trend toward the
high-end of the previously-announced full year 2013 targets.

Conference Call

On Assignment will hold a conference call today at 1:30 p.m. PDT (4:30 EDT) to
review its first quarter financial results. The dial-in number is 877-837-4158
(+1-281-913-8521 for callers outside the United States) and the conference ID
number is 40202602. Participants should dial in ten minutes before the call. A
replay of the conference call will be available beginning today at 4:30 p.m.
PDT and ending at 9:00 p.m. EDT on Friday, May 24, 2013. The access number for
the replay is 855-859-2056 (1+404-537-3406 for callers outside the United
States) and the conference ID number 40202602.

This call is being webcast byThomson/CCBN and can be accessed via On
Assignment's web site at www.onassignment.com. Individual investors can also
listen atThomson/CCBN's site at www.fulldisclosure.com or by visiting any of
the investor sites inThomson/CCBN's Individual Investor Network.

About On Assignment

On Assignment, Inc. (NYSE: ASGN), is a leading global provider of in-demand,
skilled professionals in the growing technology, healthcare and life sciences
sectors, where quality people are the key to success.The Companygoes beyond
matching résumés with job descriptions to match people they know into
positions they understand for temporary, contract-to-hire, and direct hire
assignments. Clients recognize On Assignment for their quality candidates,
quick response, and successful assignments. Professionals think of On
Assignment as career-building partners with the depth and breadth of
experience to help them reach their goals.

On Assignment was founded in 1985 and went public in 1992. The corporate
headquarters are located in Calabasas, California, with a network of 129
branch offices throughout the United States, Canada, United Kingdom,
Netherlands, Ireland and Belgium. Additionally, physicianplacements are made
in Australia and New Zealand. To learn more, visit
http://www.onassignment.com.

Reasons for Presentation of Non-GAAP Financial Measures

Statements made in this release and the Supplemental Financial Information
accompanying this release include non-GAAP financial measures. Such
information is provided as additional information, not as an alternative to
our consolidated financial statements presented in accordance with GAAP, and
is intended to enhance an overall understanding of our current financial
performance. The Supplemental Financial Information sets forth financial
measures reviewed by our management to evaluate our operating performance.
Such measures also are used to determine a portion of the compensation for
some of our executives and employees. We believe the non-GAAP financial
measures provide useful information to management, investors and prospective
investors by excluding certain charges and other amounts that we believe are
not indicative of our core operating results. These non-GAAP measures are
included to provide management, our investors and prospective investors with
an alternative method for assessing our operating results in a manner that is
focused on the performance of our ongoing operations and to provide a more
consistent basis for comparison between quarters. One of the non-GAAP
financial measures presented is EBITDA (earnings before interest, taxes,
depreciation, and amortization of identifiable intangible assets), other terms
include Adjusted EBITDA (EBITDA plus equity-based compensation expense,
impairment charges, acquisition related costs and strategic planning costs)
and Income from Continuing Operations Before Acquisition Related Costs (Income
from continuing operations, plus acquisition related expenses, deferred
financing fees written-off and non-recurring financing fees, net of tax) and
Adjusted Income from Continuing Operations and related per share amounts.
These terms might not be calculated in the same manner as, and thus might not
be comparable to, similarly titled measures reported by other companies. The
financial statement tables that accompany this press release include
reconciliation of each non-GAAP financial measure to the most directly
comparable GAAP financial measure.

Safe Harbor

Certain statements made in this news release are “forward-looking statements”
within the meaning of Section21E of the Securities Exchange Act of 1934, as
amended, and involve a high degree of risk and uncertainty. Forward-looking
statements include statements regarding the Company's anticipated financial
and operating performance in 2013. All statements in this release, other than
those setting forth strictly historical information, are forward-looking
statements. Forward-looking statements are not guarantees of future
performance, and actual results might differ materially. In particular, the
Company makes no assurances that the estimates of revenues, gross margin,
SG&A, Adjusted EBITDA, income from continuing operations, adjusted income from
continuing operations, earnings per share or earnings per diluted share set
forth above will be achieved. Factors that could cause or contribute to such
differences include actual demand for our services, our ability to attract,
train and retain qualified staffing consultants, our ability to remain
competitive in obtaining and retaining temporary staffing clients, the
availability of qualified temporary nurses and other qualified temporary
professionals, management of our growth, continued performance of our
enterprise-wide information systems, and other risks detailed from time to
time in our reports filed with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the year ended December 31, 2012,
as filed with the SEC on March 18, 2013. We specifically disclaim any
intention or duty to update any forward-looking statements contained in this
news release.

                                      
                                         
SUMMARY CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share amounts)
                                         
                                         
                                         Three Months Ended
                                         March 31,               December 31,
                                         2013        2012        2012
                                                                  
Revenues                                 389,193      156,760     380,381
Cost of services                         275,919     104,011    264,762    
Gross profit                             113,274      52,749      115,619
Selling, general and administrative      84,161       42,745      80,226
expenses
Amortization of intangible assets        5,379       634        11,857     
Operating income                         23,734       9,370       23,536
Interest expense                         (5,331   )   (701    )   (5,675     )
Income before income taxes               18,403       8,669       17,861
Provision for income taxes               7,793       3,622      8,113      
Income from continuing operations        10,610       5,047       9,748
Gain on sale of discontinued             14,412       —           —
operations, net of tax
Income (loss) from discontinued          (409     )   336        1,574      
operations, net of tax
Net income                               $ 24,613    $ 5,383    $  11,322  
                                                                  
Basic earnings per common share:
Income from continuing operations        $ 0.20       $ 0.14      $  0.19
Income from discontinued operations      0.26        —          0.03       
                                         $ 0.46      $ 0.14     $  0.22    
                                                                  
Diluted earnings per common share:
Income from continuing operations        $ 0.20       $ 0.13      $  0.18
Income from discontinued operations      0.26        0.01       0.03       
                                         $ 0.46      $ 0.14     $  0.21    
                                                                  
Number of shares and share
equivalents used to calculate
earnings per share:
Basic                                    53,046      37,269     52,581     
Diluted                                  54,036      38,154     53,680     
                                                                             
                                                                             

               
                    
SUPPLEMENTAL SEGMENT FINANCIAL INFORMATION (Unaudited)

(In thousands)
                    
                    
                   Three Months Ended
                  March 31,              December 31,
                  2013       2012        2012
Revenues:
Technology –
Apex              $ 212,728   $ —         $   207,576
Oxford             95,262    78,759         90,410
                    307,990   78,759          297,986
                                              
Life Sciences       40,473    41,351          40,293
Healthcare          14,428    12,561          16,030
Physician          26,302    24,089         26,072
                  $ 389,193   $ 156,760   $   380,381
                                              
Gross profit:
Technology –
Apex              $ 55,619    $ —         $   56,752
Oxford             32,150    27,370         31,777
                    87,769    27,370          88,529
                                              
Life Sciences       13,384    13,839          14,225
Healthcare          4,638     4,041           4,997
Physician          7,483     7,499          7,868
                  $ 113,274   $ 52,749    $   115,619
                                              
                                              

                                       
                                            
SELECTED CASH FLOW INFORMATION (Unaudited)

(In thousands)
                                            
                                            
                                          Three Months Ended
                                          March 31,             December 31,
                                          2013        2012      2012
Cash (used in) provided by operations     $ (2,869 )   $ 6,973   $   26,059
Capital expenditures                      $ 2,785      $ 2,119   $   3,471
                                                                     
                                                                     

                                                             
SELECTED CONSOLIDATED BALANCE SHEET DATA (Unaudited)

(In thousands)
                                                                 
                                                                 
                                        March 31,                December 31,
                                        2013        2012        2012
Cash and cash equivalents               $  8,237     $ 17,685    $   27,479
Accounts receivable, net                257,196      102,026     243,003
Goodwill and intangible assets, net     755,904      260,626     762,196
Total assets                            1,089,899    419,989     1,098,021
Current portion of long-term debt       10,000       5,000       10,000
Total current liabilities               125,362      62,541      118,727
Working capital                         166,461      75,764      175,030
Long-term debt                          373,588      75,500      416,588
Other long-term liabilities             29,166       25,932      29,983
Stockholders’ equity                    561,783      256,016     532,723
                                                                 
                                                                 

                     
                        
RECONCILIATION OF GAAP INCOME FROM CONTINUING OPERATIONS AND EARNINGS PER SHARE TO
NON-GAAP ADJUSTED EBITDA AND ADJUSTED EBITDA PER DILUTED SHARE (Unaudited)

(In thousands, except per share amounts)
                        
                        
                        Three Months Ended
                        March 31,                                  December 31,
                        2013                 2012                  2012
Income from
continuing              $ 10,610  $ 0.20     $ 5,047   $ 0.13     $ 9,748   $ 0.18
operations
Interest expense,       5,331      0.10       701        0.02       5,675      0.11
net
Provision for           7,793      0.14       3,622      0.09       8,113      0.15
income taxes
Depreciation            1,855      0.03       1,410      0.04       1,838      0.03
Amortization of         5,379      0.10      634        0.02      11,857     0.22
intangibles
EBITDA                  30,968     0.57       11,414     0.30       37,231     0.69
Equity-based            2,550      0.05       1,172      0.03       3,112      0.06
compensation
Acquisition-related     161        0.00       2,492      0.07       402        0.01
costs
Strategic planning      457        0.01      —          —         —          —
costs
Adjusted EBITDA         $ 34,136   $ 0.63    $ 15,078   $ 0.40    $ 40,745   $ 0.76
                                                         
Weighted average
common and common
equivalent shares       54,036                38,154                53,680
outstanding
(diluted)
                                                                               
                                                                               

                                                                 
                                                                             
NON-GAAP CALCULATION OF ADJUSTED EARNINGS PER SHARE (Unaudited)

Three Months Ended March 31, 2013

(In thousands, except per share amounts)
                                                                             
Income from Continuing Operations - GAAP Basis                      $ 10,610
Adjustments:
Amortization of intangible assets (1)                               5,379
Cash tax savings on indefinite-lived intangible assets (2)          3,850
Excess of capital expenditures over depreciation, net of tax        (1,050   )
(3)
Income from Continuing Operations - As Adjusted                     $ 18,789 
                                                                    
Earnings per Diluted Share from Continuing Operations:
GAAP Basis                                                          $ 0.20   
As Adjusted                                                         $ 0.35   
                                                                    
Weighted average common and common equivalent shares                54,036   
outstanding (diluted)
                                                                             

(1)   Amortization of intangible assets of acquired businesses.
        
        Cash tax savings on indefinite-lived intangible assets (goodwill and
        trademarks related to acquisition of Apex Systems, Oxford and
        HealthCare Partners) that are amortized and deductible in the
        determination of income taxes, but not amortized for financial
(2)     reporting purposes. These assets total $593.1 million and are
        amortized (and deducted) for income tax purposes on a straight-line
        basis over 15 years. The annual income tax deduction is $39.5 million
        and the annual after-tax cash savings are approximately $15.4 million,
        assuming an estimated marginal combined federal and state income tax
        rate of 39 percent.
        
        Excess capital expenditures over depreciation is equal to one-quarter
        of the estimated full year difference between capital expenditures
(3)     (full year estimate of $15.9 million) less depreciation (full year
        estimate of $9.0 million), tax affected using an estimated marginal
        combined federal and state tax rate of 39 percent.
        
        

                     
                        
RECONCILIATION OF GAAP INCOME FROM CONTINUING OPERATIONS AND EARNINGS PER SHARE TO
NON-GAAP INCOME FROM CONTINUING OPERATIONS BEFORE ACQUISITION-RELATED COSTS AND
EARNINGS PER SHARE BEFORE ACQUISITION-RELATED COSTS (Unaudited)

(In thousands, except per share amounts)
                        
                        
                        Three Months Ended
                        March 31,                                 December 31,
                        2013                 2012                 2012
Income from
continuing              $ 10,610  $ 0.20     $ 5,047  $ 0.13     $ 9,748    $ 0.18
operations
Acquisition-related
costs, net of           93         —         1,451     0.04      (56     )   —
income taxes
Income from
continuing
operations before       $ 10,703   $ 0.20    $ 6,498   $ 0.17    $ 9,692    $ 0.18
acquisition-related
costs
                                                                   
Weighted average
common and common
equivalent shares       54,036               38,154               53,680     
outstanding
(diluted)
                                                                               
                                                                               

                                                                  
                                                                         
PRO FORMA OPERATING RESULTS FROM CONTINUING OPERATIONS (Unaudited)

Year Ended December 31, 2012

(In thousands)
                                                                         
                                                                         
                 Q1            Q2            Q3            Q4            Full Year
Revenues         $ 342,721     $ 362,179     $ 374,512     $ 380,381     $ 1,459,793
Cost of          240,652      250,583      258,882      264,762      1,014,879
services
Gross profit     102,069       111,596       115,630       115,619       444,914
SG&A             77,397        77,172        77,009        78,912        310,490
expenses
Amortization
of               6,381        6,349        6,309        6,299        25,338
intangible
assets
Operating        $ 18,291     $ 28,075     $ 32,312     $ 30,408     $ 109,086
income
                                                                         
Adjusted         $ 28,425      $ 38,855      $ 43,532      $ 41,659      $ 152,471
EBITDA
___

The above unaudited pro forma results were prepared on the basis that the
acquisition of Apex Systems occurred on January 1, 2012 and the divesture of
the Nurse Travel division occurred on December 31, 2011. These results differ
from the pro forma disclosures included in the Company's 2012 Form 10-K as
those pro forma results were prepared on the basis that the acquisition of
Apex Systems occurred on January 1, 2011 and the Nurse Travel division was
included in continuing operations. SG&A expenses, operating income and
Adjusted EBITDA included a $0.5 million and $1.0 million benefit in Q2 and Q3,
respectively, related to the reduction in the earnout obligation for
HealthCare Partners.

                                                                                              
                                                                                                     
SUPPLEMENTAL FINANCIAL INFORMATION – REVENUES AND GROSS MARGINS (Unaudited)

(Dollars in thousands)
                                                                                                     
                                                                                                     
                   Technology
                   Apex         Oxford      Total         Life          Healthcare    Physician    Consolidated
                                                            Sciences
Revenues:
Q1 2013            $ 212,728     $ 95,262     $ 307,990     $ 40,473      $ 14,428      $ 26,302     $  389,193
Q4 2012            $ 207,576     $ 90,410     $ 297,986     $ 40,293      $ 16,030      $ 26,072     $  380,381
% Sequential       2.5       %   5.4      %   3.4       %   0.4      %    (10.0    )%   0.9      %   2.3        %
change
Q1 2012            —             $ 78,759     $ 78,759      $ 41,351      $ 12,561      $ 24,089     $  156,760
%
Year-over-year     N/M           21.0     %   291.1     %   (2.1     )%   14.9     %    9.2      %   148.3      %
change
                                                                                                     
Gross margins:
Q1 2013            26.1      %   33.7     %   28.5      %   33.1     %    32.1     %    28.5     %   29.1       %
Q4 2012            27.3      %   35.1     %   29.7      %   35.3     %    31.2     %    30.2     %   30.4       %
Q1 2012            —         %   34.8     %   34.8      %   33.5     %    32.2     %    31.1     %   33.6       %
                                                                                                     
Average number
of staffing
consultants:
Q1 2013            671           540          1,211         176           89            107          1,583
Q4 2012            658           547          1,205         178           86            108          1,577
Q1 2012            —             487          487           169           78            95           829
_______
N/M – not
meaningful
                                                                                                     

                                                                                       
                Technology
                Apex        Oxford      Total        Life         Healthcare   Physician    Consolidated
                                                       Sciences
Average
number of
customers:
Q1 2013         600          659          1,259        884          479          173          2,795
Q4 2012         606          651          1,257        935          519          180          2,891
Q1 2012         —            625          625          918          478          175          2,196
                                                                                              
Top 10
customers
as a
percentage
of revenue:
Q1 2013         33.5     %   16.7     %   23.5     %   24.8     %   29.6     %   21.6     %   18.6       %
Q4 2012         34.4     %   15.8     %   24.7     %   23.3     %   30.6     %   22.1     %   19.3       %
Q1 2012         —            15.6     %   15.6     %   22.6     %   25.6     %   22.0     %   9.8        %
                                                                                              
Average
bill rate:
Q1 2013         $ 59.62      $ 122.47     $ 69.88      $ 34.94      $ 38.01      $ 185.92     $  64.21
Q4 2012         $ 58.74      $ 122.23     $ 69.52      $ 35.13      $ 37.48      $ 184.57     $  63.45
Q1 2012         $ —          $ 117.61     $ 117.61     $ 34.88      $ 36.74      $ 175.63     $  67.82
                                                                                              
Gross
profit per
staffing
consultant:
Q1 2013         $ 83,000     $ 60,000     $ 72,000     $ 76,000     $ 52,000     $ 70,000     $  72,000
Q4 2012         $ 86,000     $ 58,000     $ 73,000     $ 80,000     $ 58,000     $ 73,000     $  73,000
Q1 2012         $ —          $ 56,000     $ 56,000     $ 82,000     $ 52,000     $ 79,000     $  64,000
                                                                                                         
                                                                                                         

                             
                                  
SUPPLEMENTAL FINANCIAL INFORMATION – KEY METRICS (Unaudited)
                                  
                                  
                                 Three Months Ended
                                 March 31,   December 31,
                                  2013          2012
Percentage of revenues:
Top ten clients                   18.6%             19.3%
Direct hire/conversion            1.9%              1.8%
                                                    
Bill rate:
% Sequential change               1.2%              0.1%
% Year-over-year change           (5.3)%            (4.6)%
                                                    
Bill/Pay spread:
% Sequential change               0.7%              (0.2)%
% Year-over-year change           (13.7)%           (12.9)%
                                                    
Average headcount:
Contract professionals (CP)       11,583            11,602
Staffing consultants (SC)         1,583             1,577
                                                    
Productivity:
Gross profit per SC             $ 72,000        $   73,000
                                                    

Contact:

On Assignment, Inc.
Ed Pierce
Chief Financial Officer
(818) 878-7900
 
Press spacebar to pause and continue. Press esc to stop.